This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Cha University Industry-Academic Cooperation Foundation, Ewha University-Industry Collaboration Foundation, Yonsei University. Active years: 2025.
Company Filing History:
1 out of 8 
1 out of 204 
1 out of 1,470 
Years Active: 2025
Title: Eosu Kim: Innovator in Cancer Treatment
Introduction
Eosu Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the prevention, amelioration, and treatment of cancer, showcasing his dedication to improving health outcomes.
Latest Patents
Eosu Kim holds a patent for a composition aimed at preventing, ameliorating, or treating cancer. The patent describes alpha-beta unsaturated aryl, heteroaryl, and cycloalkylene ketone compounds that are effective in inhibiting the growth of cancer cells. This innovative approach not only targets cancer cells but also inhibits their metastasis to other tissues, offering hope for more effective cancer therapies. He has 1 patent to his name.
Career Highlights
Throughout his career, Eosu Kim has been associated with notable institutions that emphasize collaboration between academia and industry. His work has been instrumental in bridging the gap between research and practical applications in the medical field.
Collaborations
Eosu Kim has collaborated with various organizations, including Ewha University-Industry Collaboration Foundation and Cha University Industry-Academic Cooperation Foundation. These partnerships have allowed him to leverage resources and expertise to advance his research.
Conclusion
Eosu Kim's contributions to cancer treatment through his innovative patent highlight his role as a key figure in the field. His dedication to research and collaboration underscores the importance of innovation in addressing critical health challenges.